NVTAQ Invitae Corp
- 0.000
- -0.006-93.85%
Invitae Corp News
US Bankruptcy Court Approves Invitae Sale to Labcorp
Labcorp to Buy Assets of Bankrupt Invitae for $239M
By Colin Kellaher Laboratory Corp. of America won the bidding for the assets of bankrupt medical-genetics company Invitae. The companies late Wednesday said Labcorp will acquire substantially all of
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.
Invitae Publishes Its Environmental, Social and Governance (ESG) Report
Invitae Reports Q4 Results
Genetic Test Provider Invitae (OTC:NVTA) Files for Bankruptcy
Invitae Files for Chapter 11 Bankruptcy to Address Huge Debt Load
Genetic Testing Firm Invitae, Backed by SoftBank and Cathie Wood, Files for Chapter 11
Invitae Is a Medical Genetics Company >NVTA
Invitae Is a Medical Genetics Company >NVTA
Invitae: Transaction Support Agreement Includes Commitment From Noteholders to Support Sale Process >NVTA
Invitae: Transaction Support Agreement Includes Commitment From Noteholders to Support Sale Process >NVTA
Invitae Making Ch 11 Filing With Support of Senior Secured Noteholders >NVTA
Invitae Making Ch 11 Filing With Support of Senior Secured Noteholders >NVTA
Invitae Intends to Transition Into Chapter 11 Without Disrupting Operations >NVTA
Invitae Intends to Transition Into Chapter 11 Without Disrupting Operations >NVTA
Invitae: Has Sought Court Approval to Fund Case Using Cash on Hand >NVTA
Invitae: Has Sought Court Approval to Fund Case Using Cash on Hand >NVTA
Invitae Files For Voluntary Chapter 11 Protection; Pursues Sale Process >NVTA
Invitae Files For Voluntary Chapter 11 Protection; Pursues Sale Process >NVTA
Invitae Faces NYSE Delisting Over Low Trading Prices
NYSE to Commence Delisting Proceedings Against Invitae Corporation (NVTA)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE" or "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Inv
Invitae Falls To US$0.089, But Insiders Sold At Lower Price
Despite the fact that Invitae Corporation's (NYSE:NVTA) value has dropped 78% in the last week insiders who sold US$229k worth of stock in the past 12 months have had less success. Insiders might hav
Express News | Invitae Shares Are Trading Lower Following a Report Suggesting the Company Is Preparing for Bankruptcy
InVitae Halted, News Pending
Sector Update: Health Care Stocks Advance Monday Afternoon
Health care stocks rose Monday afternoon with the NYSE Health Care Index adding 0.6% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.3%. In cor
Analysis
Price Target
No Data
